Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1169132 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Mitochondrial Antiviral Signaling Protein (MAVS) (AA 160-450) antibody
- Antibody type
- Monoclonal
- Antigen
- Recombinant human Cardif (aa 160-450).
- Description
- Purified from concentrated hybridoma tissue culture supernatant.
- Reactivity
- Human
- Host
- Mouse
- Epitope
- AA 160-450
- Isotype
- IgG
- Antibody clone number
- Adri-1
- Vial size
- 100 μg
- Concentration
- 1mg/ml
- Storage
- Stable for at least 1 year after receipt when stored at -20°C.
Submitted references Quantitative proteomics identifies the membrane-associated peroxidase GPx8 as a cellular substrate of the hepatitis C virus NS3-4A protease.
Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon system.
TRADD protein is an essential component of the RIG-like helicase antiviral pathway.
Morikawa K, Gouttenoire J, Hernandez C, Dao Thi VL, Tran HT, Lange CM, Dill MT, Heim MH, Donzé O, Penin F, Quadroni M, Moradpour D
Hepatology (Baltimore, Md.) 2014 Feb;59(2):423-33
Hepatology (Baltimore, Md.) 2014 Feb;59(2):423-33
Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon system.
Bellecave P, Sarasin-Filipowicz M, Donzé O, Kennel A, Gouttenoire J, Meylan E, Terracciano L, Tschopp J, Sarrazin C, Berg T, Moradpour D, Heim MH
Hepatology (Baltimore, Md.) 2010 Apr;51(4):1127-36
Hepatology (Baltimore, Md.) 2010 Apr;51(4):1127-36
TRADD protein is an essential component of the RIG-like helicase antiviral pathway.
Michallet MC, Meylan E, Ermolaeva MA, Vazquez J, Rebsamen M, Curran J, Poeck H, Bscheider M, Hartmann G, König M, Kalinke U, Pasparakis M, Tschopp J
Immunity 2008 May;28(5):651-61
Immunity 2008 May;28(5):651-61
No comments: Submit comment
No validations: Submit validation data